News & analysis
Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Nuformix PLC is a pharmaceutical development company. It is focused on building value for shareholders through its activities in drug development and by out-licensing. The company uses cocrystal technology to re-engineer the crystalline form of known small molecule drugs. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.
Latest NFX News
NFX Regulatory News